09:01 AM EST, 01/13/2025 (MT Newswires) -- Harmony Biosciences Holdings ( HRMY ) said Monday it expects Q4 net product revenue of $201 million.

Analysts polled by FactSet expect $198.6 million.

The company reported preliminary 2024 net product revenue for the year ended Dec. 31 of $714 million, falling within its guidance for $700 million to $720 million.

Analysts surveyed by FactSet expect $712.1 million.

Harmony said it expects 2025 net product revenue of between $820 and $860 million. Analysts polled by FactSet expect $847.3 million.

Shares of the company were up more than 6% in recent Monday premarket activity.